Enfortumab vedotin is supplied under the trade name Padcev. It is a novel therapeutic drug approved by the FDA and has a positive role in the management of metastatic urothelial cancer. Clinical research outcomes suggest its significance in the treatment of recurrent bladder cancer and urothelial carcinoma. This therapeutic drug is developed by Astellas Pharma. Padcev (enfortumab vedotin) injection in India is a noted recommendation by medical oncologists.
This innovative drug is available as 20 mg and 30 mg single-use vial lyophilized powder for solution for IV infusion only, at a dose of 1.25 mg/kg (up to a maximum of 125 mg for patients ≥ 100 kg), administered intravenously (IV) over a half-hour on days 1, 8, and 15 of a 28-day cycle until disease progression or unacceptable toxicity.
Padcev 20 mg/ 30 mg vials in India may be prescribed after due consultations with the patient. Its limited access is clearly because of the registration status in India. Since this medicine is not formally registered, this limits direct availability in pharmacies. However, this does not entirely prevent India-based patients from obtaining this medicinal product. Provisions like the Named Patient Program (NPP) are available to import Padcev (enfortumab vedotin) legally.
Searching for Padcev (Enfortumab Vedotin) in India? We Can Help:
If you are looking to buy Enfortumab Vedotin in India, we can assist you in procuring the medicine. Our experienced team helps patients connect with legitimate suppliers who can supply the medicine legally to India. We have a track record of assisting India-based patients with the necessary documentation and procedures. The sources or suppliers we connect you with are duly authorized/licensed to help facilitate the import of Padcev (Enfortumab Vedotin) in India.
Why Padcev is Important for Indian Patients:
For Indian patients suffering from metastatic urothelial cancer, Padcev provides a crucial treatment option, especially when other therapies like chemotherapy or immunotherapy have failed. It targets a protein commonly found on cancer cells, which allows for more effective treatment with fewer healthy cells being affected.
With an increasing number of bladder cancer cases being reported in India, it’s becoming clear that access to advanced treatments like Padcev is of great importance. Indian oncologists are recognizing this drug’s potential for helping patients live longer, with better quality of life, by slowing down the progression of their disease. Although Padcev is not registered in India, its success in global clinical trials has led to an increasing number of patients seeking to import it legally under specialized access programs.
Conclusion:
While Padcev is not formally registered in India, programs like the Named Patient Program (NPP) allow eligible patients to legally obtain the medicine. Whether you are a patient or a clinician, knowing the options to access life-saving drugs like Padcev is crucial. If you need assistance with the importation process, kindly reach out to us through our TOLL-FREE helpline: 1800-889-1064 or connect with us via Call/WhatsApp: +91 9310090915.
Frequently Asked Questions (FAQs):
What is Padcev used for?
Padcev (Enfortumab Vedotin) is used to treat locally advanced or metastatic urothelial cancer, especially for patients who have not responded to other treatments like chemotherapy or immunotherapy.
Is Padcev available in India?
Padcev is not formally available in India, but patients can access it through the Named Patient Program (NPP), which allows for the legal importation of unregistered drugs.
How is Padcev administered?
Padcev is administered intravenously at a dose of 1.25 mg/kg of body weight on days 1, 8, and 15 of a 28-day cycle until the disease progresses or the side effects become intolerable.
Can Indian patients legally import Padcev?
Yes, Indian patients can legally import Padcev under the Named Patient Program (NPP), which allows access to medications that are not yet registered in the country. Patients and their clinicians can contact us via Call/WhatsApp: +91 9310090915 to buy Padcev online in India and other countries where the medicine is not approved or unavailable.
What are the side effects of Padcev?
Common side effects include fatigue, skin rash, decreased appetite, and nerve damage. It’s essential to discuss all potential side effects with your doctor before starting the treatment.
